Intellia Therapeutics

ISIN US45826J1051

WKN A2AG6H

Marktkapitalisatie (in EUR)

1,257 m

Land

United States

Sector

Healthcare

Dividendrendement

0.00%

|One app for all your investments. Buy crypto, stocks and ETFs easily with Bitpanda. Learn more

Overzicht

Koers

Beschrijving

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Toon meer Toon minder

Healthcare Biopharmaceuticals Other Biopharmaceuticals United States

Grafiek

Financiële kerngegevens

Kerncijfers

Marktkapitalisatie, EUR	1,257 m
WPA, EUR	-3.39
KBV	2.2
K/W	-
Dividendrendement	0.00%

Winst- en verliesrekening (2025)

Omzet, EUR	60 m
Netto-inkomen, EUR	-366 m
Winstmarge	-609.85%

In welke ETF zit Intellia Therapeutics?

Er zijn 3 ETF's die Intellia Therapeutics bevatten. Al deze ETF's staan in de tabel hieronder. De ETF met de grootste weging van Intellia Therapeutics is de iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).

ETF	Weging	Investeringsfocus	Fondsgrootte (in m EUR)
Amundi MSCI Disruptive Technology UCITS ETF Acc	0,02%	Aandelen Wereld Technologie Sociaal/Milieu Innovatie	139
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)	0,12%	Aandelen Verenigde Staten Gezondheidszorg Biotech	46
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist)	0,02%	Aandelen Verenigde Staten Small Cap	202

Prestaties

Rendementsoverzicht

YTD	+36,49%
1 maand	-0,74%
3 maanden	-8,10%
6 maanden	+12,21%
1 jaar	+48,06%
3 jaar	-69,11%
5 jaar	-83,82%
Since inception	-54,31%
2025	-31,31%
2024	-60,73%
2023	-11,25%
2022	-69,20%

Maandelijks rendement in een heat map

Risico

Risk metrics in this section:

Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.

ETF-rendementen zijn inclusief dividenduitkeringen (indien van toepassing).